Ribonucleic Acid (RNA) Extraction Kits Market Global Report 2026

The ribonucleic acid (RNA) extraction kits market size has grown rapidly in recent years. It will grow from $2.27 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing adoption of molecular diagnostics in clinical laboratories, expansion of genomic and transcriptomic research studies, rising prevalence of infectious and genetic diseases requiring rna analysis, growth in pharmaceutical r&d activities, standardization of laboratory workflows for nucleic acid extraction.

The ribonucleic acid (RNA) extraction kits market size is expected to see rapid growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized therapeutics, expansion of next generation sequencing based applications, increasing automation in sample preparation workflows, growth in decentralized and point of care diagnostic testing, rising investments in biotechnology and life science research infrastructure. Major trends in the forecast period include automated high-throughput rna isolation systems for large scale molecular workflows, ultra pure contamination free rna extraction enhancing downstream sequencing accuracy, microfluidic based sample preparation platforms enabling rapid rna purification, portable and point of care molecular extraction kits for decentralized diagnostics, cost optimized spin column and magnetic bead based extraction formats improving laboratory efficiency.

The increasing genomic research is expected to propel the growth of the ribonucleic acid (RNA) extraction kits market going forward. Genomic research encompasses scientific investigations involving gene sequencing, transcriptomics, molecular biology, and genetic analysis for applications across healthcare and life sciences. The growth in genomic research is driven by the expanding adoption of next-generation sequencing (NGS) technologies, which provide faster, more precise, and cost-effective genetic material analysis. Ribonucleic acid (RNA) extraction kits facilitate genomic research by enabling the efficient isolation and purification of high-quality RNA from biological samples for downstream genetic analysis, supporting accurate gene expression profiling and molecular characterization. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, by the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II clinical development, and this figure increased by 5% to 260 therapies by the end of the second quarter (Q2) 2023. Therefore, the increasing genomic research is driving the growth of the ribonucleic acid (RNA) extraction kits market.

The rising prevalence of infectious diseases is expected to propel the growth of the ribonucleic acid (RNA) extraction kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, that spread through direct or indirect transmission. The increase in infectious diseases is mainly attributed to rapid urbanization, as densely populated urban areas encourage closer human contact and accelerate disease transmission. RNA extraction kits support infectious disease diagnostics by enabling the efficient isolation and purification of viral RNA from clinical samples for accurate molecular testing. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising prevalence of infectious diseases is driving the growth of the ribonucleic acid (RNA) extraction kits market.

Major companies operating in the ribonucleic acid (RNA) extraction kit market are emphasizing the development of automated extraction systems, including magnetic bead-based viral nucleic acid extraction kits, to improve nucleic acid purification efficiency, enhance viral detection sensitivity, and optimize high-throughput laboratory workflows. A magnetic bead-based viral nucleic acid extraction kit is a laboratory solution designed to isolate and purify viral deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from biological samples using magnetic bead separation technology. For instance, in April 2024, New England Biolabs, a US-based life sciences company, introduced the Monarch Mag Viral DNA or RNA Extraction Kit to enable rapid, high-yield, and automated viral nucleic acid purification for sensitive molecular diagnostics and infectious disease detection. The kit employs magnetic bead-based extraction chemistry to deliver highly sensitive viral RNA recovery and automated, hands-free processing across a range of liquid handling platforms. It also supports scalable purification of saliva, respiratory swab, and wastewater samples for sequencing and molecular diagnostic applications.

Major companies operating in the ribonucleic acid (RNA) extraction kits market report are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Life Sciences, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Omega Bio-tek Inc., Illumina Inc., Revvity Inc., Covaris LLC, GenScript Biotech Corporation.

North America was the dominating region in the ribonucleic acid (RNA) extraction kits market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) extraction kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) extraction kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.